TABLE 3.
Gene no. | Designation | Change (fold)
|
|
---|---|---|---|
ΔcyaA/wild type | Δcrp/wild type | ||
Biofilm matrix production genes | |||
VC0916 | vpsU | 3.76 | 3.35 |
VC0917 | vpsA | 1.51 | |
VC0918 | vpsB | 2.93 | 2.16 |
VC0919 | vpsC | 2.36 | 2.37 |
VC0922 | vpsF | 2.04 | |
VC0928 | rbmA | 5.89 | 5.45 |
VC0929 | rbmB | 2.83 | 3.57 |
VC0930 | rbmC | 21.04 | 8.01 |
VC0931 | rbmD | 2.30 | |
VC0932 | rbmE | 7.46 | 4.27 |
VC0933 | rbmF | 5.89 | 5.99 |
VC0935 | vpsM | 12.75 | 8.06 |
VC0936 | vpsN | 2.63 | 2.32 |
VC0937 | vpsO | 1.61 | 1.99 |
VC0939 | vpsQ | 2.73 | 2.84 |
VC0583 | hapR | 0.11 | 0.48 |
VC1888 | bap1 | 7.84 | 6.28 |
VCA0952 | vpsT | 74.62 | 48.70 |
c-di-GMP signaling genes: GGDEF and EAL | |||
VC0072 | 1.91 | 2.53 | |
VC0653 | rocS | 1.81 | |
VC0658 | cdgI | 2.95 | 3.34 |
VC0703 | mbaA | 1.78 | 1.77 |
VC1934 | 0.42 | 0.44 | |
VC2750 | 1.70 | ||
VCA0785 | cdgC | 1.53 | |
c-di-GMP signaling genes: only GGDEF | |||
VC1029 | cdgB | 1.88 | 2.17 |
VC1067 | cdgH | 1.58 | |
VC1216 | 0.56 | 0.45 | |
VC1353 | 0.53 | ||
VC1367 | cdgE | 0.64 | |
VC1370 | 0.37 | ||
VC1376 | 1.99 | ||
VC1599 | 0.44 | 0.40 | |
VCA0049 | 0.58 | ||
VCA0074 | cdgA | 1.61 | |
VCA0165 | 0.56 | ||
VCA0217 | 1.94 | ||
VCA0697 | cdgD | 0.09 | 0.11 |
VCA0956 | cgdF | 1.90 | 1.87 |
VCA0965 | 0.31 | 0.50 | |
c-di-GMP signaling genes: only EAL | |||
VC0137 | 1.69 | 1.93 | |
VC1086 | 0.38 | 0.40 | |
VC1211 | 1.58 | ||
VC1641 | 1.66 | 2.56 | |
VC1710 | 0.21 | 0.29 | |
c-di-GMP signaling genes: HD-GYP | |||
VC1087 | 0.43 | 0.55 | |
VC1348 | 0.62 | ||
VC2340 | 2.57 | ||
VC2497 | 0.54 | 0.47 | |
VCA0210 | 1.76 | ||
VCA0895 | 0.46 | 0.61 | |
VCA0931 | 0.48 |
Differentially expressed genes were determined using the SAM software with a ≥1.5-fold change in gene expression and an FDR of ≤3% as the criteria.